By Karen Roman Imviva Biotech said the FDA cleared its Investigational New Drug application for CTA313, a dual-targeted CAR-T ...

Knowable Magazine reports on a revolutionary CAR T-cell therapy, originally for cancer, now showing promise for autoimmune ...

FDA clearance allows Imviva to test CTA313, an off-the-shelf CAR T-cell therapy, in progressive MS and other autoimmune ...

Sjögren's disease is a widespread chronic autoimmune disorder that attacks the body's own glands, yet its underlying disease mechanisms remain poorly understood.

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) ...

Autoimmune neurological disorders occur when the body's immune system mistakenly attacks healthy tissues within the brain, ...

Adicet Bio (NASDAQ:ACET) outlined its near-term clinical priorities and upcoming data catalysts during a fireside chat at the ...

New research suggests GLP-1s may reduce the risks of blood clots and early death in people with both obesity and autoimmune ...

Conclusion: ATG-207 represents a differentiated immune tolerance–restoring strategy that integrates precision T cell ...

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) ...

In total, the DWP lists ten autoimmune diseases that qualify for PIP payments ...